Portage Biotech Files 6-K, Incorporates into S-8
Ticker: ATON · Form: 6-K · Filed: Mar 12, 2025 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, registration-statement, foreign-private-issuer
TL;DR
Portage Biotech filed a 6-K, linking it to their S-8. Standard reporting.
AI Summary
Portage Biotech Inc. filed a Form 6-K on March 12, 2025, to report information for the month of March 2025. The filing is incorporated by reference into their Form S-8 registration statement (File No. 333-275842). The company is registered in the British Virgin Islands and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates ongoing reporting requirements and potential equity issuances or grants related to the company's S-8 registration statement.
Risk Assessment
Risk Level: low — This is a routine filing for a public company and does not contain specific financial or operational news that would inherently increase risk.
Key Numbers
- March 2025 — Reporting Period (The period covered by this Form 6-K filing.)
- 20250312 — Filing Date (The date the Form 6-K was filed with the SEC.)
Key Players & Entities
- PORTAGE BIOTECH INC. (company) — Filer of the 6-K report
- 001-40086 (company) — SEC File Number for Portage Biotech Inc.
- 333-275842 (company) — File number for Portage Biotech Inc.'s Form S-8 registration statement
- 2834 (company) — Standard Industrial Classification code for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded.
What does it mean for this filing to be incorporated by reference into a Form S-8?
Incorporation by reference means that the information in the 6-K is considered part of the S-8 registration statement, which is typically used for employee stock plans or offerings.
What industry does Portage Biotech Inc. operate in?
Portage Biotech Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.
Where is Portage Biotech Inc. incorporated?
Portage Biotech Inc. is incorporated in the British Virgin Islands, with its principal executive offices located in Tortola.
What is the SEC file number for Portage Biotech Inc.?
The SEC file number for Portage Biotech Inc. is 001-40086.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 12, 2025 regarding PORTAGE BIOTECH INC. (ATON).